Medicare Enrolled
Dr. Jeffrey Albores, M.D.
Critical Care Medicine · Tacoma, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Albores from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Albores?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Albores
Dr. Jeffrey Albores is a critical care medicine specialist in Tacoma, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Albores performed 1,716 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Albores received a total of $9,402 from 37 pharmaceutical and/or device companies across 500 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Albores is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 4% volume in WA
$9,402 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,716
Medicare services
Top 4% in WA for critical care medicine
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
401 | $89 | $142 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
276 | $162 | $373 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
219 | $91 | $175 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
179 | $6 | $95 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
129 | $60 | $90 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
120 | $6 | $62 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
99 | $9 | $30 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
92 | $7 | $90 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $59 | $120 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
25 | $63 | $338 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
25 | $11 | $65 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
23 | $30 | $700 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $107 | $226 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
18 | $8 | $16 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $130 | $280 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
15 | $87 | $781 |
| Lung airway sensitivity test A test used to measure the sensitivity of the airways in the lungs. |
15 | $21 | $127 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
15 | $79 | $180 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
1.5% medium
97.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,402
Total received (2018-2024)
Avg $1,343/year across 7 years
Top 3% in WA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
500
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$639
2023
$850
2022
$1,946
2021
$1,681
2020
$1,071
2019
$1,863
2018
$1,351
Payments by company (2024)
Gilead Sciences, Inc.
$107
GENZYME CORPORATION
$87
GlaxoSmithKline, LLC.
$80
Merck Sharp & Dohme LLC
$68
United Therapeutics Corporation
$68
AstraZeneca Pharmaceuticals LP
$58
Actelion Pharmaceuticals US, Inc.
$50
Baxter Healthcare
$31
Regeneron Healthcare Solutions, Inc.
$26
Insmed, Inc.
$23
Grifols USA, LLC
$22
Alexion Pharmaceuticals, Inc.
$20
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
Actelion Pharmaceuticals US, Inc.
$1,604
GlaxoSmithKline, LLC.
$1,580
AstraZeneca Pharmaceuticals LP
$1,058
Boehringer Ingelheim Pharmaceuticals, Inc.
$828
United Therapeutics Corporation
$719
Insmed, Inc.
$648
Gilead Sciences, Inc.
$505
GENZYME CORPORATION
$456
Mylan Specialty L.P.
$230
Philips Electronics North America Corporation
$210
Genentech USA, Inc.
$135
Merck Sharp & Dohme LLC
$121
Fisher & Paykel Healthcare Inc
$112
Relypsa, Inc.
$107
SANOFI-AVENTIS U.S. LLC
$96
Grifols USA, LLC
$95
Regeneron Healthcare Solutions, Inc.
$93
Mallinckrodt Enterprises LLC
$89
Electromed, Inc.
$79
Baxter Healthcare
$77
Alexion Pharmaceuticals, Inc.
$68
Bayer Healthcare Pharmaceuticals Inc.
$59
Advanced Respiratory, Inc
$55
Amgen Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$51
Circassia Pharmaceuticals Inc
$49
Shire North American Group Inc
$39
Merck Sharp & Dohme Corporation
$35
PORTOLA PHARMACEUTICALS, INC.
$31
Novartis Pharmaceuticals Corporation
$20
La Jolla Pharmaceutical Company
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Paratek Pharmaceuticals, Inc.
$13
Olympus America Inc.
$13
Sunovion Pharmaceuticals Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
120V · 60Hz · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Andexxa · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · DUAKLIR PRESSAIR · DUPIXENT · Dymista · ELIQUIS · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · POMPE - DISEASE · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · ULTOMIRIS · UPTRAVI · Veklury · Veltassa · WINREVAIR · XOLAIR · Xembify · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
29
County median income
$96,632
Nearest hospital to ZIP centroid (approximate)
ST JOSEPH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Albores is a clinical cardiology specialist, with above-average Medicare volume (top 4% in WA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Albores experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Albores performed 401 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Albores receive payments from pharmaceutical companies?
Yes. Dr. Albores received a total of $9,402 from 37 companies across 500 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Albores's costs compare to other critical care medicines in Tacoma?
Dr. Albores's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Albores) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Tacoma
Browse critical care medicines in Tacoma ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in WA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in WA
Which WA critical care medicines receive the most from drug and device companies.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology